16 Nov 2021 Research

John Goldman Fellowships for 2022 open in December

Leukaemia UK is delighted to announce that we are funding more ground-breaking research in 2022, by continuing our investment in early career scientists and clinicians for our prestigious John Goldman Fellowships.

Applications for the annual fellowship programme open on 1st December 2021 to scientists and clinician-scientists working in UK universities, research institutions or hospitals. There is no age limit, although the fellowship programme is designed to provide funding at a critical point in a researcher’s career – the transition to becoming an independent researcher.

We have now increased the maximum award available to £150,000, to span a minimum 18-month and maximum 2-year period.

The John Goldman Fellowships were created in honour of Professor John Goldman (1938 – 2013), a renowned haematologist and pioneer in the treatment of leukaemia.

The awards are aimed at early career researchers with a passion for science, a desire to develop new ideas and translate scientific advances into clinical practice.

Successful applicants will show that they are the potential scientific/clinical leaders of the future. Their proposed research project must be novel with the capacity to make advances in our knowledge of leukaemia and related diseases and the development of new and kinder treatments.

Find out more about the 2021 John Goldman Fellows and their research projects:

Dr Daniel Coleman- AML: Developing kinder treatments by targeting mutated RAS

Dr Pramila Krishnamurthy – Understanding how donor lymphocyte infusion can prevent leukaemia patients from relapsing after a stem cell transplant

Dr Samanta Mariani – Investigating the role of macrophages in infant leukaemia

Dr William Grey (pictured above) – Could targeting the repertoire of proteins in AML lead to improved survival for the most at risk patients?

Dr Giulia Orlando (pictured right) – The role of RAS in Juvenile Myelomonocytic Leukaemia-finding new therapies?

Applications for the 2022 fellowships close on 31st January 2022. Find out more about the application process.

Related posts

Less than 1% of Brits can identify all the most common symptoms of one of the deadliest types of cancer

4 September 2023

Less than 1% of Brits can identify all the most common symptoms of one of the deadliest types of cancer

New research launched today by Leukaemia Care and Leukaemia UK reveals that less than 1% (0.4%) of UK adults can accurately identify the four most common symptoms of leukaemia –…

Nick Boles’ Ambulatory Care Unit opening speech

15 June 2018

Nick Boles’ Ambulatory Care Unit opening speech

An edited extract of the speech Nick Boles MP made at the official opening of the Leukaemia UK Ambulatory Care Unit.

The first ever leukaemia-dedicated pathway to improve diagnosis, treatment and care

8 July 2025

The first ever leukaemia-dedicated pathway to improve diagnosis, treatment and care

The Best Practice Timed Pathway We’re delighted to share that Leukaemia UK, in partnership with Lymphoma Action and Myeloma UK, is working with the NHS England Cancer programme team to…

Leukaemia UK is looking for volunteers for their Patient Experience Advisory Panel

4 June 2022

Leukaemia UK is looking for volunteers for their Patient Experience Advisory Panel

Leukaemia UK is committed to championing advancements in better treatments and care for all. We want to ensure the needs of patients are at the heart of everything we do, and that the voices of people affected by leukaemia and related conditions are being heard. That is why we are setting up a Patient Experience Advisory Panel.